CenterStar Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.3M Buy
+15,000
New +$1.44M 0.16% 138
2025
Q4
Sell
-2,100
Closed -$200K 350
2025
Q3
$200K Buy
+2,100
New +$193K 0.04% 268
2025
Q2
Sell
-66,400
Closed -$5.97M 318
2025
Q1
$5.97M Buy
+66,400
New +$5.94M 1.42% 11
2024
Q4
Sell
-62,600
Closed -$5.64M 326
2024
Q3
$5.64M Buy
62,600
+49,100
+364% +$4.13M 1.13% 11
2024
Q2
$1.06M Buy
13,500
+9,400
+229% +$771K 0.3% 73
2024
Q1
$357K Sell
4,100
-1,500
-27% -$128K 0.11% 184
2023
Q4
$461K Sell
5,600
-24,800
-82% -$1.89M 0.07% 195
2023
Q3
$2.38M Buy
+30,400
New +$2.54M 0.49% 25
2022
Q2
Hold
0
-$7.24M 545
2022
Q1
Hold
0
21
2021
Q2
Hold
0
-$14.9M 603
2021
Q1
Hold
0
10
2020
Q4
Hold
0
8
2020
Q3
Hold
0
6
2020
Q2
Hold
0
8
2019
Q2
Hold
0
-$7K 394
2019
Q1
Hold
0
292
2018
Q4
Hold
0
450
2018
Q3
Hold
0
668
2018
Q2
Hold
0
209
2018
Q1
Hold
0
97
2017
Q4
Hold
0
391

Other funds holding MDT

CenterStar Asset Management's MDT Position: Q1 2026 in Review

CenterStar Asset Management opened a new position in Medtronic (MDT) in Q1 2026: 5,048 shares worth $437K. The stake represents 0.05% of the portfolio and ranks #346 among its holdings. This is a return to the name: CenterStar Asset Management previously reported a position in MDT as recently as Q1 2025.

CenterStar Asset Management first reported a position in MDT in Q3 2023 and has held it in 3 quarters since. The position peaked at $2.12M in Q3 2023. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • CenterStar Asset Management held 5,048 shares of Medtronic worth $437K as of Q1 2026.
  • Medtronic was a new CenterStar Asset Management position in Q1 2026.
  • Medtronic made up 0.05% of CenterStar Asset Management's portfolio in Q1 2026, its #346 holding.
  • CenterStar Asset Management first reported a position in Medtronic in Q3 2023 and has held it in 3 quarters since.
  • CenterStar Asset Management's Medtronic position peaked at $2.12M in Q3 2023.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on CenterStar Asset Management's 13F filing for Q1 2026, filed 1 May 2026.